Literature DB >> 17211677

Lymph node metastasis detection of ovarian cancer by porphyrin fluorescence photodetection: case report.

Peter Hillemanns1, Jessica Reiff, Herbert Stepp, Philipp Soergel.   

Abstract

The concept of intraoperative in vivo diagnosis and selective resection of infiltrated lymph nodes in ovarian cancer has not been evaluated despite the increased morbidity associated with pelvic and paraaortic lymph node dissection and its questionable therapeutic value. Fluorescence photodetection is based on the application of a photosensitizer relatively selective for malignant tissue, which after light activation of appropriate wavelength, shows fluorescence. Six hours after oral application of 10 mg/kg body weight 5-aminolevulinic acid, the abdominal cavity of a patient with suspicion of recurrent ovarian cancer was inspected using a laparoscope and blue light at 380-440 nm. Spectral measurements at a wavelength of 635 nm, multiple peritoneal biopsies, and lymph node excisions were performed. White light inspection and porphyrin fluorescence photodetection revealed no intraperitoneal metastases and multiple biopsies were negative. Fluorescence-positive lymph nodes were visible only in the left common iliac region and a specific porphyrin fluorescence peak could be detected. In contrary, no increased porphyrin fluorescence of intraperitoneal tissues or skin was seen. Fluorescence microscopy showed the characteristic red fluorescence in the infiltrated parts of the lymph node tissue by the papillary ovarian cancer. Histology of the other sites was negative. No systemic or cutaneous side effects were recorded. This data is a proof of the concept that porphyrin fluorescence-guided lymph node metastasis detection is possible in ovarian cancer and should stimulate further research in this field.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211677     DOI: 10.1007/s10103-006-0428-4

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  10 in total

1.  Feasibility study to detect ovarian cancer micrometastases by fluorescence photodetection.

Authors:  A L Major; F Lüdicke; A Campana; A Campand
Journal:  Lasers Med Sci       Date:  2002       Impact factor: 3.161

2.  Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.

Authors:  R L Friedman; S M Eisenkop; H J Wang
Journal:  Gynecol Oncol       Date:  1997-10       Impact factor: 5.482

Review 3.  A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance.

Authors:  Thorsten Kuehn; Andreas Bembenek; Thomas Decker; Dieter Ludwig Munz; Marie-Luise Sautter-Bihl; Michael Untch; Diethelm Wallwiener
Journal:  Cancer       Date:  2005-02-01       Impact factor: 6.860

4.  Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy.

Authors:  C Menon; S N Kutney; S C Lehr; S K Hendren; T M Busch; S M Hahn; D L Fraker
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

5.  Photodetection of cervical intraepithelial neoplasia using 5-aminolevulinic acid-induced porphyrin fluorescence.

Authors:  P Hillemanns; H Weingandt; R Baumgartner; J Diebold; W Xiang; H Stepp
Journal:  Cancer       Date:  2000-05-15       Impact factor: 6.860

6.  Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.

Authors:  N M Spirtos; S M Eisenkop; J B Schlaerth; S C Ballon
Journal:  Am J Obstet Gynecol       Date:  2000-06       Impact factor: 8.661

7.  Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy.

Authors:  T Onda; H Yoshikawa; H Yokota; T Yasugi; Y Taketani
Journal:  Cancer       Date:  1996-08-15       Impact factor: 6.860

8.  Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX.

Authors:  Martin Löning; Heyke Diddens; Wolfgang Küpker; Klaus Diedrich; Gereon Hüttmann
Journal:  Cancer       Date:  2004-04-15       Impact factor: 6.860

9.  Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis.

Authors:  John J Wilson; Heather Jones; Marc Burock; Debbie Smith; Douglas L Fraker; James Metz; Eli Glatstein; Stephen M Hahn
Journal:  Int J Oncol       Date:  2004-03       Impact factor: 5.650

Review 10.  Photodynamic therapy.

Authors:  T J Dougherty; S L Marcus
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.